Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-1998 | 06-1998 | 03-1998 | |
Sales | 1,230 | 1,020 | 898 |
Cost of Goods | 1,130 | 1,090 | 1,150 |
Gross Profit | 90 | -70 | -250 |
Operating Expenses | 1,150 | 1,390 | 1,260 |
Operating Income | -920 | -1,370 | -1,362 |
Interest Expense | 20 | 10 | 20 |
Other Income | 30 | 30 | 402 |
Pre-tax Income | -910 | -1,350 | -980 |
Net Income Continuous | -916 | -1,358 | -989 |
Net Income | $-916 | $-1,358 | $-989 |
EPS Basic Total Ops | -0.20 | -0.30 | -0.23 |
EPS Basic Continuous Ops | -0.20 | -0.31 | -0.23 |
EPS Diluted Total Ops | -0.20 | -0.30 | -0.23 |
EPS Diluted Continuous Ops | -0.20 | -0.31 | -0.23 |
EBITDA(a) | $-740 | $-1,190 | $-1,192 |